Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 10, 2010, Pages 2665-2672

  Pio, Ruben ^a,b   Garcia, Javier ^c   Corrales, Leticia ^a   Ajona, Daniel ^a   Fleischhacker, Michael ^e   Pajares, Maria J ^a,d   Cardenal, Felipe ^f   Seijo, Luis ^c   Zulueta, Javier J ^c   Nadal, Ernest ^f   Witt, Christian ^e   Lozano, Maria D ^c   Schmidt, Bernd ^e   Montuenga, Luis M ^a,d  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d UNIVERSITY OF NAVARRA   (Spain)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; COMPLEMENT FACTOR H; HEMOGLOBIN;

ADULT; AGED; ARTICLE; CYTOLOGY; FEMALE; HUMAN; HUMAN CELL; LUNG CANCER; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN SECRETION; SENSITIVITY AND SPECIFICITY; SPUTUM;

BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; COHORT STUDIES; COMPLEMENT FACTOR H; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SPUTUM; TUMOR MARKERS, BIOLOGICAL;

EID: 77958034853     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0467     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Fraser RS, Muller NL, Colman N, Pare PD. Endoscopy and diagnostic biopsy procedures. In: Fraser RS, Muller NL, Colman N, Pare PD, editors. Fraser and Pare's diagnosis of diseases of the chest. 4th ed. Philadelphia (PA): WB Saunders; 1999, p. 366-78.
3. Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest 2003;123:115-28S.
4. Trevisani L, Putinati S, Sartori S, Abbasciano V, Bagni B. Cytokeratin tumor marker levels in bronchial washing in the diagnosis of lung cancer. Chest 1996;109:104-8.
5. Pardos MC, Alvarez-Sala R, Terreros Caro FJ, Gomez L, Gomez de Terreros FJ, Villamor J. The concentrations of five tumor markers in both BAL fractions in lung cancer patients in relation to cigarette smoking. Tumori 1999;85:454-7. (Pubitemid 30074591)
6. Pina TC, Zapata IT, Hernandez FC, Lopez JB, Paricio PP, Hernandez PM. Tumour markers in serum, bronchoalveolar lavage and biopsy cytosol in lung carcinoma: what environment lends the optimum diagnostic yield? Clin Chim Acta 2001;305:27-34.
7. Sen S, Reddy VG, Khanna N, Guleria R, Kapila K, Singh N. A comparative study of telomerase activity in sputum, bronchial washing and biopsy specimens of lung cancer. Lung Cancer 2001;33:41-9.
8. Carstensen T, Schmidt B, Engel E, Jandrig B, Witt C, Fleischhacker M. Detection of cell-free DNA in bronchial lavage fluid supernatants of patients with lung cancer. Ann N Y Acad Sci 2004;1022:202-10. (Pubitemid 38951603)
9. Engel E, Schmidt B, Carstensen T, et al. Detection of tumor-specific mRNA in cell-free bronchial lavage supernatant in patients with lung cancer. Ann N Y Acad Sci 2004;1022:140-6.
10. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer - a survey. Biochim Biophys Acta 2007;1775:181-232. (Pubitemid 44911084)
11. Liloglou T, Maloney P, Xinarianos G, et al. Cancer-specific genomic instability in bronchial lavage: a molecular tool for lung cancer detection. Cancer Res 2001;61:1624-8.
12. Sokolova IA, Bubendorf L, O'Hare A, et al. A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimens. Cancer 2002;96:306-15.
13. Arvanitis DA, Papadakis E, Zafiropoulos A, Spandidos DA. Fractional allele loss is a valuable marker for human lung cancer detection in sputum. Lung Cancer 2003;40:55-66. (Pubitemid 36344066)
14. Bubendorf L, Muller P, Joos L, et al. Multitarget FISH analysis in the diagnosis of lung cancer. Am J Clin Pathol 2005;123:516-23.
15. Kim H, Kwon YM, Kim JS, et al. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. J Clin Oncol 2004;22:2363-70.
16. Topaloglu O, Hoque MO, Tokumaru Y, et al. Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. Clin Cancer Res 2004;10:2284-8. (Pubitemid 38445685)
17. Ajona D, Castano Z, Garayoa M, et al. Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement. Cancer Res 2004;64:6310-8.
18. Ajona D, Hsu YF, Corrales L, Montuenga LM, Pio R. Down-regulation of human complement factor H sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growth. J Immunol 2007;178:5991-8.
19. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological typing of lung and pleural tumours. Berlin: Springer-Verlag; 1999.
20. Charokopos N, Leotsinidis M, Tsiamita M, et al. Increased levels of albumin in bronchial washing fluid of patients with bronchial carcinoma. Could albumin be considered as a tumor marker? Int J Biol Markers 2004;19:316-21.
21. Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 1988;133:95-109.
22. Weis SM. Vascular permeability in cardiovascular disease and cancer. Curr Opin Hematol 2008;15:243-9.
23. Gratton JP, Lin MI, Yu J, et al. Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. Cancer Cell 2003;4:31-9.
24. Velluti G, Capelli O, Lusuardi M, et al. Bronchoalveolar lavage in the normal lung. First of three parts: protein, enzymatic and ionic features. Respiration 1983;44:403-10.